MAP3K2 and neoplasm: Mechanistically, this was the result of tumor EV-EGFR driven Mitogen-Activated Protein Kinase Kinase Kinase 2 (MEKK2) phosphorylation, inhibiting IRF3 dimerization and IFN production.